Open in App
  • Local
  • U.S.
  • Election
  • Politics
  • Crime
  • Sports
  • Lifestyle
  • Education
  • Real Estate
  • Newsletter
  • Reuters

    Japan health ministry panel backs Eli Lilly dementia drug donanemab

    By Reuters,

    4 hours ago
    https://img.particlenews.com/image.php?url=4aMI6S_0uk8UCfW00

    TOKYO (Reuters) - A Japanese health ministry panel on Thursday recommended approval for Eli Lilly's dementia treatment donanemab.

    Formal approval is expected shortly after the panel's vote, which would make the drug Japan's second approved treatment for Alzheimer's disease after Leqembi, developed by Eisai and Biogen.

    Donanemab, sold under the brand name Kisunla, was approved by the U.S. Food and Drug Administration early last month.

    (Reporting by Rocky Swift; Editing by Andrew Heavens)

    Expand All
    Comments / 0
    Add a Comment
    YOU MAY ALSO LIKE
    Most Popular newsMost Popular
    The New York Times29 days ago

    Comments / 0